Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial

Stock Information for Spectral Medical Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Spectral Medical Inc

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update
Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine
Spectral Medical Provides Update on PMA Submission Timing for PMX-20R
Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.